Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men

被引：52
作者：
Corona G. [1 ]
Bianchini S. [1 ]
Sforza A. [1 ]
Vignozzi L. [2 ]
Maggi M. [2 ]
机构：
[1] Endocrinology Unit, Maggiore-Bellaria Hospital, Medical Department, Azienda-Usl Bologna, Bologna
[2] Sexual Medicine and Andrology Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence
来源：
Hormones | 2015年 / 14卷 / 4期
关键词：
Erectile dysfunction; Metabolic syndrome; Obesity; Testosterone;
D O I：
10.14310/horm.2002.1635
中图分类号：
学科分类号：
摘要：
There is evidence demonstrating that sexual complaints represent the most specific symptoms associated with late onset hypogonadism, while central obesity is the most specific sign. In obese men, hypogonadism can further worsen the metabolic profile and increase abdominal fat. In addition, although hypogonadism can exacerbate obesity-associated erectile dysfunction (ED), recent data suggest that a direct contribution of fat-derived factors could be hypothesized. In particular, an animal model recently documented that fat accumulation induces several hepatic pro-inflammatory genes closely linked to corpora cavernosa endothelial dysfunction. Lifestyle modifications and weight loss are the first steps in the treatment of ED patients with obesity or metabolic diseases. In symptomatic hypogonadal men with metabolic impairment and obesity, combining the effect of testosterone substitution with lifestyle modifications could result in better outcomes. © 2015, Hellenic Endocrine Society. All Right reserved.
引用
收藏
页码：569 / 578
页数：9
相关论文
共 81 条
  • [1] Gray A., Feldman H.A., McKinlay J.B., Longcope C., Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study, J Clin Endocrinol Metab, 73, pp. 1016-1025, (1991)
  • [2] Ferrini R.L., Barrett-Connor E., Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men, Am J Epidemiol, 147, pp. 750-754, (1998)
  • [3] Harman S.M., Metter E.J., Tobin J.D., Pearson J., Blackman M.R., Baltimore Longitudinal Study of Aging, Longitudinal effects of aging on serum total and free testosterone levels in healthy men, Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab, 86, pp. 724-731, (2001)
  • [4] Morley J.E., Kaiser F.E., Perry H.M., Et al., Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men, Metabolism, 46, pp. 410-413, (1997)
  • [5] Wu F.C., Tajar A., Pye S.R., Et al., Hypothalamicpituitary- testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The European Male Aging Study, J Clin Endocrinol Metab, 93, pp. 2737-2745, (2008)
  • [6] Tajar A., Forti G., O'Neill T.W., Et al., Characteristics of secondary, primary, and compensated hypogonadism in aging men: Evidence from the European Male Ageing Study, J Clin Endocrinol Metab, 95, pp. 1810-1818, (2010)
  • [7] Buvat J., Maggi M., Guay A., Torres L.O., Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment, J Sex Med, 10, pp. 245-284, (2013)
  • [8] Wang C., Nieschlag E., Swerdloff R., Et al., Investigation, treatment and monitoring of late-onset hypogonadism in males, Int J Androl, 32, pp. 1-10, (2009)
  • [9] Corona G., Rastrelli G., Vignozzi L., Mannucci E., Maggi M., How to recognize late-onset hypogonadism in men with sexual dysfunction, Asian J Androl, 14, pp. 251-259, (2012)
  • [10] Corona G., Rastrelli G., Maggi M., Diagnosis and treatment of late-onset hypogonadism: Systematic review and meta-analysis of TRT outcomes, Best Pract Res Clin Endocrinol Metab, 27, pp. 557-579, (2013)
123456789